Detalles de la búsqueda
1.
Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.
BMC Cancer
; 23(1): 1112, 2023 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964214
2.
Health-state utilities in long-term advanced melanoma survivors comparable with the general population.
Qual Life Res
; 32(9): 2517-2525, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079262
3.
Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.
Gynecol Oncol
; 165(3): 459-465, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35414427
4.
Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.
BMC Cancer
; 21(1): 464, 2021 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33902498
5.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
BMC Cancer
; 19(1): 420, 2019 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31060544
6.
(Cost-)effectiveness of an internet-based physical activity support program (with and without physiotherapy counselling) on physical activity levels of breast and prostate cancer survivors: design of the PABLO trial.
BMC Cancer
; 18(1): 1073, 2018 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30400784
7.
A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning.
Ann Oncol
; 32(10): 1212-1215, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34400293
8.
Scenario drafting for early technology assessment of next generation sequencing in clinical oncology.
BMC Cancer
; 16: 66, 2016 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26851938
9.
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer.
Br J Cancer
; 111(5): 837-42, 2014 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25003667
10.
Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients.
Ann Oncol
; 30(5): 663-665, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31038154
11.
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms.
Breast Cancer Res Treat
; 145(3): 697-705, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24760482
12.
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.
Int J Cancer
; 133(4): 929-36, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23371464
13.
"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care.
J Cancer Surviv
; 2023 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606816
14.
Integration of a smoking cessation program in the treatment protocol for patients with head and neck and lung cancer.
Eur Arch Otorhinolaryngol
; 269(2): 659-65, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21698416
15.
Securing sustainable price levels of innovative anticancer drugs: How to move forward?
J Cancer Policy
; 27: 100266, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35559942
16.
Effects of and Lessons Learned from an Internet-Based Physical Activity Support Program (with and without Physiotherapist Telephone Counselling) on Physical Activity Levels of Breast and Prostate Cancer Survivors: The PABLO Randomized Controlled Trial.
Cancers (Basel)
; 13(15)2021 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359567
17.
Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing.
Value Health
; 17(7): A652, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202357
18.
Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy.
Value Health
; 17(7): A323, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27200529
19.
Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients.
Value Health
; 17(7): A640, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202291
20.
Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer.
Value Health
; 17(7): A644, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202312